α-Synuclein shares physical and functional homology with 14-3-3 proteins

被引:456
作者
Ostrerova, N
Petrucelli, L
Farrer, M
Mehta, N
Choi, P
Hardy, J
Wolozin, B
机构
[1] Loyola Univ, Med Ctr, Dept Pharmacol, Maywood, IL 60154 USA
[2] Mayo Clin Jacksonville, Dept Pharmacol, Jacksonville, FL 32224 USA
关键词
14-3-3; proteins; Alzheimer's disease; apoptosis; BAD; extracellular regulated kinase; Parkinson's disease; protein kinase C; synuclein;
D O I
10.1523/JNEUROSCI.19-14-05782.1999
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
alpha-Synuclein has been implicated in the pathophysiology of many neurodegenerative diseases, including Parkinson's disease (PD) and Alzheimer's disease. Mutations in alpha-synuclein cause some cases of familiar PD (Polymeropoulos et at., 1997; Kruger et al., 1998). In addition, many neurodegenerative diseases show accumulation of alpha-synuclein in dystrophic neurites and in Lewy bodies (Spillantini et al., 1998). Here, we show that alpha-synuclein shaves physical and functional homology with 14-3-3 proteins, which are a family of ubiquitous cytoplasmic chaperones. Regions of alpha-synuclein and 14-3-3 proteins share over 40% homology. In addition, alpha-synuclein binds to 14-3-3 proteins, as well as some proteins known to associate with 14-3-3, including protein kinase C, BAD, and extracellular regulated kinase, but not Raf-l. We also show that overexpression of alpha-synuclein inhibits protein kinase C activity. The association of alpha-synuclein! with BAD and inhibition of protein kinase C suggests that increased expression of alpha-synuclein could be harmful. Consistent with this hypothesis, we observed that overexpression of wild-type alpha-synuclein is toxic, and overexpression of alpha-synuclein containing the A53T or A30P mutations exhibits even greater toxicity. The activity and binding profile of alpha-synuclein suggests that it might act as a protein chaperone and that accumulation of alpha-synuclein could contribute to cell death in neurodegenerative diseases.
引用
收藏
页码:5782 / 5791
页数:10
相关论文
共 39 条
[1]   POSTTRANSLATIONALLY MODIFIED 14-3-3-ISOFORMS AND INHIBITION OF PROTEIN-KINASE-C [J].
AITKEN, A ;
HOWELL, S ;
JONES, D ;
MADRAZO, J ;
MARTIN, H ;
PATEL, Y ;
ROBINSON, K .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 149 :41-49
[2]   Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis [J].
Atwood, CS ;
Moir, RD ;
Huang, XD ;
Scarpa, RC ;
Bacarra, NME ;
Romano, DM ;
Hartshorn, MK ;
Tanzi, RE ;
Bush, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :12817-12826
[3]   AMYLOID-BETA PEPTIDE INDUCES NECROSIS RATHER THAN APOPTOSIS [J].
BEHL, C ;
DAVIS, JB ;
KLIER, FG ;
SCHUBERT, D .
BRAIN RESEARCH, 1994, 645 (1-2) :253-264
[4]   Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function [J].
Broadie, K ;
Rushton, E ;
Skoulakis, EMC ;
Davis, RL .
NEURON, 1997, 19 (02) :391-402
[5]   The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease [J].
Clayton, DF ;
George, JM .
TRENDS IN NEUROSCIENCES, 1998, 21 (06) :249-254
[6]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320
[7]   MULTIPLE SEQUENCE ALIGNMENT WITH HIERARCHICAL-CLUSTERING [J].
CORPET, F .
NUCLEIC ACIDS RESEARCH, 1988, 16 (22) :10881-10890
[8]   Stabilization of α-synuclein secondary structure upon binding to synthetic membranes [J].
Davidson, WS ;
Jonas, A ;
Clayton, DF ;
George, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9443-9449
[9]   Structure and sites of phosphorylation of 14-3-3 protein: Role in coordinating signal transduction pathways [J].
Dubois, T ;
Howell, S ;
Amess, B ;
Kerai, P ;
Learmonth, M ;
Madrazo, J ;
Chaudhri, M ;
Rittinger, K ;
Scarabel, M ;
Soneji, Y ;
Aitken, A .
JOURNAL OF PROTEIN CHEMISTRY, 1997, 16 (05) :513-522
[10]   Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease [J].
El-Agnaf, OMA ;
Jakes, R ;
Curran, MD ;
Wallace, A .
FEBS LETTERS, 1998, 440 (1-2) :67-70